Senseonics receives CE Mark for implantable continuous glucose monitoring system

Senseonics’ offering is a pill-sized sensor that is entirely implanted in the user’s upper arm so that it can continuously monitor their glucose levels. The device is meant to last at least 90 days before it needs to be replaced — in contrast to the five to seven days that current not-quite-so-invasive CGMs last. Goodnow said the company would begin commercialization in Sweden in partnership with the company’s exclusive distributor, Rubin Medical.”